Ulf Hannelius

Inga fler pågående positioner

Förmögenhet: 49 548 $ per 2026-08-31

51 år

13 relationer

Consumer Services

Health Technology

Technology Services

Profil

Ulf Hannelius is currently Chairman at Diamyd Biomanufacturing AB and Director at Mainly AB since 2021.
Formerly, Dr. Hannelius was President & Chief Executive Officer at Diamyd Medical AB from 2016 to 2026.
Education includes a doctorate from Karolinska Institutet and an MBA from Stockholm School of Economics.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
DIAMYD MEDICAL AB CLASS B 0,31 %	2025-08-31	463 973 ( 0,31 % )	49 548 $	2026-08-31

Aktiva positioner av Ulf Hannelius

Företag	Position	Start
Mainly AB Mainly AB Packaged SoftwareTechnology Services Develops an AI research engineer platform	Direktör/Styrelseledamot	2021-02-22

Alla aktiva positioner av Ulf Hannelius

Tidigare kända positioner av Ulf Hannelius

Företag	Position	Slut
DIAMYD MEDICAL AB	Verkställande Direktör	2026-04-22

Se detaljerna i Ulf Hanneliuss erfarenhet

Ulf Hanneliuss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Ulf Hanneliuss erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stockholm School of Economics Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Diamyd Medical AB Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes	Health Technology
Mainly AB Mainly AB Packaged SoftwareTechnology Services Develops an AI research engineer platform	Technology Services